Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04087161
Other study ID # 29012015
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 1, 2019
Est. completion date December 30, 2022

Study information

Verified date April 2024
Source RWTH Aachen University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Assessment of postoperative acute kidney insufficiency according to the KDIGO classification using the Nephrocheck system. Multicentric, prospective study Open TAAA Repair in 3-4 centers in Germany and Europe


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date December 30, 2022
Est. primary completion date April 25, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: elective open TAAA repai 18-80 years no pregnancy Exclusion Criteria: emergency treatment participation in another Trial renal replacement therapy

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Nephrocheck bed side testing of AKI
Usage of Nephrocheck system to assess AKI after open TAAA repair

Locations

Country Name City State
Germany University Hospital RWTH Aachen Aachen NRW

Sponsors (3)

Lead Sponsor Collaborator
RWTH Aachen University Berlin, University medicine Charité, Department of Vascular Surgery, Münster, University Hospital, Department of Vascular Surgery

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Acute kidney injury after open TAAA repair Acute kidney injury defined according to the KDIGO classification and its association with the Nephrocheck assessment results 90 days after surgery
Secondary Mortality, major adverse events such as any complication Any severe adverse Outcome after open TAAA repair and its association with the Nephrocheck assessment results 90 days after surgery